HomeCompareZOM vs PLD

ZOM vs PLD: Dividend Comparison 2026

ZOM yields 2055.50% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZOM wins by $12828287188.51M in total portfolio value
10 years
ZOM
ZOM
● Live price
2055.50%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12828287195.01M
Annual income
$11,707,825,857,181,476.00
Full ZOM calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — ZOM vs PLD

📍 ZOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZOMPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZOM + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZOM pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZOM
Annual income on $10K today (after 15% tax)
$174,717.37/yr
After 10yr DRIP, annual income (after tax)
$9,951,651,978,604,254.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, ZOM beats the other by $9,951,651,974,136,284.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZOM + PLD for your $10,000?

ZOM: 50%PLD: 50%
100% PLD50/50100% ZOM
Portfolio after 10yr
$6414143600.76M
Annual income
$5,853,912,931,218,956.00/yr
Blended yield
91.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ZOM
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-0.0
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZOM buys
0
PLD buys
0
No recent congressional trades found for ZOM or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZOMPLD
Forward yield2055.50%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$12828287195.01M$6.50M
Annual income after 10y$11,707,825,857,181,476.00$5,256,436.18
Total dividends collected$12748926998.50M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ZOM vs PLD ($10,000, DRIP)

YearZOM PortfolioZOM Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$216,250$205,549.85$11,255$555.24+$205.0KZOM
2$4,385,604$4,154,217.05$13,062$1,018.59+$4.37MZOM
3$83,429,631$78,737,034.33$15,903$1,926.67+$83.41MZOM
4$1,489,134,673$1,399,864,967.60$20,839$3,823.32+$1489.11MZOM
5$24,944,940,636$23,351,566,535.79$30,464$8,166.08+$24944.91MZOM
6$392,269,666,568$365,578,580,087.90$52,054$19,457.30+$392269.61MZOM
7$5,792,510,495,062$5,372,781,951,834.12$109,886$54,188.93+$5792510.39MZOM
8$80,345,661,782,925$74,147,675,553,208.94$304,030$186,451.18+$80345661.48MZOM
9$1,047,160,128,816,172$961,190,270,708,442.20$1,166,125$840,813.32+$1047160127.65MZOM
10$12,828,287,195,014,780$11,707,825,857,181,476.00$6,504,190$5,256,436.18+$12828287188.51MZOM

ZOM vs PLD: Complete Analysis 2026

ZOMStock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Full ZOM Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ZOM vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZOM vs SCHDZOM vs JEPIZOM vs OZOM vs KOZOM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.